Michael H. Davidson
CIK 1573785 · Chief Executive Officer · last filed 2026-06-12
Michael H. Davidson is a Chief Executive Officer who has filed 29 SEC Form 4 insider transactions across 6 companies since 2020. The most recent filing, for BIOA, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$25.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.71M
6
29
-$25.06M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIOA | Director | — | $21.92 | — | $0 | 3 | 2026-06-12 |
| NAMSW | Chief Executive Officer | 459,859 | $19.38 | $8.91M | -$25.16M | 9 | 2026-03-02 |
| TENX | Director | 2,881 | $15.80 | $45.5K | $0 | 5 | 2026-01-13 |
| SLN | Director | — | $11.55 | — | $0 | 1 | 2025-01-06 |
| THC | Director | 2,881 | $262.63 | $756.6K | $0 | 1 | 2024-08-08 |
| LISATA THERAPEUTICS, INC. (CLBS) Delisted | Director | 13,984 | $6.40 | $89.4K | $99.9K | 4 | 2022-01-12 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | BIOA | Grant (A) | — | $0 | EDGAR |
| 2026-03-02 | NAMS | Notice (144) | −443,707 | -$15.73M | EDGAR |
| 2026-03-02 | NAMSW | Mixed | — | -$14.75M | EDGAR |
| 2026-02-26 | NAMSW | Mixed | — | -$10.58M | EDGAR |
| 2026-02-24 | NAMS | Notice (144) | −750,000 | -$27.13M | EDGAR |
| 2026-01-13 | TENX | Grant (A) | — | $0 | EDGAR |
| 2026-01-09 | NAMSW | Mixed | +69,418 | $0 | EDGAR |
| 2026-01-07 | NAMS | Notice (144) | −11,582 | -$410.9K | EDGAR |
| 2025-07-03 | TENX | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | BIOA | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.